ImportRefusal LogoImportRefusal

SPIMACO

⚠️ Moderate Risk

FEI: 3013223024 • Al Qassim • SAUDI ARABIA

FEI

FEI Number

3013223024

📍

Location

Al Qassim

🇸🇦
🏢

Address

Pharmaceutical Plant, , Al Qassim, , Saudi Arabia

Moderate Risk

FDA Import Risk Assessment

41.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
11/18/2022
Latest Refusal
8/24/2017
Earliest Refusal

Score Breakdown

Violation Severity
73.3×40%
Refusal Volume
22.3×30%
Recency
22.2×20%
Frequency
5.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3421×

PERSONALRX

The article appears to be a drug which requires a prescription from your doctor.

Refusal History

DateProductViolationsDivision
11/18/2022
61WDY46ITRACONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/12/2020
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
342PERSONALRX
75UNAPPROVED
Division of Northern Border Imports (DNBI)
8/24/2017
56DCE06AMIKACIN SULFATE (AMINOGLYCOSIDES)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is SPIMACO's FDA import refusal history?

SPIMACO (FEI: 3013223024) has 3 FDA import refusal record(s) in our database, spanning from 8/24/2017 to 11/18/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. SPIMACO's FEI number is 3013223024.

What types of violations has SPIMACO received?

SPIMACO has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about SPIMACO come from?

All FDA import refusal data for SPIMACO is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.